All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
| SSRG / Symmetry Surgical Inc.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
| LENSF / Presbia PLC
|
|
|
|
|
|
|
|
| IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TLT / iShares Trust - iShares 20+ Year Treasury Bond ETF
|
|
|
|
|
|
|
|
| VBIV / VBI Vaccines Inc.
|
|
|
|
|
|
|
|
| FBIO / Fortress Biotech, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| USO / United States Oil Fund, LP - Limited Partnership
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MDRX / Veradigm Inc.
|
|
|
|
|
|
|
|
| US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
| USO / United States Oil Fund, LP - Limited Partnership Call
|
|
|
|
|
|
|
|
| Arrowhead Research Corp
/ (042797209) |
|
|
|
|
|
|
|
| US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
| CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CYTR / LadRx Corp
|
|
|
|
|
|
|
|
| KITE / Kite Pharma, Inc.
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BRK.B / Berkshire Hathaway Inc.
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VIVO / Meridian Bioscience Inc. Call
|
|
|
|
|
|
|
|
| VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation
|
|
|
|
|
|
|
|
| 76028H209 / Repros Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
| La Jolla Pharmaceutical Company Cmn Di
/ (000000000) |
|
|
|
|
|
|
|
| GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
| LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company Call
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TRGT / Targacept
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
